Whipsmart market research has added a new research report “Global Transfection reagents and equipment Market” to its research database. Transfection Reagents and Equipment Market is projected to grow up to USD 1502.35 million by 2027 growing at a CAGR of 7.9% during the forecasting period 2021-2027.
These Transfection reagents techniques serve as an analytical tool that smoothens the attributes of genetic functions, protein synthesis, cell growth and development. This technique not only enables the advancement of cellular research, but also helps in discovering the variety of drug strategies. There is a wide range of such reagents techniques that involves the chemical, physical and biological approach. The major factors that are driving the market growth include technological advancements in transfection, an increase in R&D expenditure and research activities by pharmaceutical and biotech companies, and a rise in demand for synthetic genes. The transfection reagents and equipment market is driven by increased focus on the development of protein therapeutics, government initiatives to support health care, and increasing prevalence of diseases such as cancer and cardiovascular diseases. In addition, increase in mass production of proteins is projected to propel the market in the near future.
The global transfection reagents and equipment market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share.
The report also includes the analysis of major players in the Transfection Reagents and Equipment market. Some of the major players consist of Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Lonza Group Ltd, Qiagen N.V, Bio–Rad Laboratories, Inc, Maxcyte, Inc, Merck KGaA, Polyplus-Transfection Sa, F. Hoffmann-La Roche Ltd, and Mirus Bio LLC.
The Transfection Reagents and Equipment market report has been categorized as below
- Calcium Phosphate
- Biomedical Research
- Gene Expression Studies
- Cancer Research
- Transgenic Model
- Protein Production
- Therapeutic Delivery
By End User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- North America
- Asia Pacific
- Rest of World
Whipsmart MI provides fact-based consulting services to B2B and B2C market to help our clients to achieve incremental and transformational growth competing in their niche market. We facilitate their growth journey through an environment that is dominated by accelerating change, constant evolution of new business models, disruptive trends and technologies in their respective industry.
The Whipsmart Market bytes platform is created specifically for B2B and B2C players with consideration of the market knowledge and interest. With over 4,000 titles to choose from diverse industries, the coverage is comprehensive and the data is updated every quarter. Whipsmart uses comples AI based algorithms to gather economic intelligence from different agencies across the globe, combines them with primary information sources and builds projections that are accurate and dependable. With multiple download options and the flexibility to source almost any kind of intelligence on demand as per market interest.
Press Release: https://whipsmartmi.com/pressrelease
Phone: +1 5102005090